ZYTIGA (Abiraterone) is a prescription medication used in combination with prednisone to treat metastatic castration-resistant prostate cancer. It works by inhibiting the production of androgens, which can fuel the growth of prostate cancer cells.
The typical recommended dosage of ZYTIGA is 1000 mg (four 250 mg tablets) taken orally once daily, in combination with prednisone 5 mg taken orally twice daily. It should be taken on an empty stomach, at least 1 hour before or 2 hours after a meal.
Common side effects of ZYTIGA may include:
Serious side effects may occur, and patients should contact their healthcare provider if they experience severe symptoms.
Avoid consuming food within 1 hour before or 2 hours after taking ZYTIGA, as this can affect absorption.
Consult your healthcare provider before taking ZYTIGA with other medications, as interactions may occur.
The duration of treatment with ZYTIGA will depend on your specific medical condition and response to therapy, as determined by your healthcare provider.